EQS-News: NEW APPOINTMENT TO BOARD OF MANAGEMENT OF STRATEC SEEQS
Im Artikel erwähnte Wertpapiere: STRATEC N
EQS-News: STRATEC SE
/ Key word(s): Personnel
NEW APPOINTMENT TO BOARD OF MANAGEMENT OF STRATEC SE
Birkenfeld, December 1, 2022
The Supervisory Board of STRATEC SE, Birkenfeld, Germany, (Frankfurt: SBS; Prime Standard, SDAX) has decided to extend the company’s Board of Management with a further member and appointed Dr. Georg Bauer to the Board with responsibility for sales as of January 1, 2023. Dr. Bauer will strengthen the existing team on the Board of Management, which already includes Marcus Wolfinger, Dr. Robert Siegle, and Dr. Claus Vielsack.
Dr. Bauer (49) has gained more than 20 years of professional experience in senior positions at technology companies with international operations. He was most recently Director of the Smart Consumables business unit and Managing Director of STRATEC Consumables GmbH, a global OEM player in the field of smart consumables for applications in diagnostics, life sciences, and medical technology. Dr. Bauer studied chemistry at Vienna University, where he obtained his doctorate in biochemistry and bioanalytical systems.
“We are delighted to welcome a proven expert in our industry to the Board of Management. Dr. Bauer has both longstanding sales experience with highly complex system solutions and all-round expertise in developing and manufacturing micro-fluidic and smart consumables. He is ideally qualified to further expand and strengthen the STRATEC Group’s leading market position as a one-stop provider of in-vitro diagnostics automation solutions. Working as a team, the Board of Management will make every effort to enable us to continue on our successful growth course and optimally satisfy our customers’ needs”, comments Marcus Wolfinger, Chief Executive Officer of STRATEC SE.
The partners market the systems, software and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of patented technologies.
Shares in the company (ISIN: DE000STRA555) are traded in the Prime Standard segment of the Frankfurt Stock Exchange and are listed in the SDAX select index of the German Stock Exchange.
01.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
|Phone:||+49 (0)7082 7916 0|
|Fax:||+49 (0)7082 7916 999|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||1503357|
|End of News||EQS News Service|
1503357 01.12.2022 CET/CEST